Understanding how membrane proteins communicate signals across cell membranes
Revealing transmembrane conformational signaling through single-molecule FRET
This study is looking at how certain proteins in our cells communicate and change shape, which is important for how our cells work, and it aims to help scientists design better drugs by using special techniques to see these proteins in action.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10932100 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which membrane proteins transmit information across cell membranes, which is crucial for cellular processes. By utilizing advanced fluorescence techniques and nanodiscs, the study aims to observe the conformational changes of these proteins in their natural environments. This approach allows for a better understanding of how these proteins function and how they can be targeted for drug design. The research focuses on improving the resolution of single-molecule spectroscopy to capture these dynamic changes effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that involve membrane protein dysfunction, such as certain cancers or metabolic disorders.
Not a fit: Patients with conditions unrelated to membrane protein signaling or those who do not have access to the research facilities may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective drug designs targeting membrane proteins, potentially improving treatments for various diseases, including cancer.
How similar studies have performed: Previous research has shown success in using fluorescence techniques to study membrane proteins, indicating that this approach has potential for significant advancements.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Schlau-Cohen, Gabriela — Massachusetts Institute of Technology
- Study coordinator: Schlau-Cohen, Gabriela
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.